TM FILINGS 2004 - NOW THE TRUTH CAN BE TOLD ...


At last, the IPKat can reveal the content of WIPO's formerly embargoed and now amended Press Release. In short:
* Use of Madrid international trade mark registration system reached a record level last year. 29,459 international applications were filed. That's up 23.5% over 2003.

* For the twelfth consecutive year Germany tops the list of biggest users with 5,393 Madrid applications (18.3%), followed by France with 3,503 (11.9%), Italy 2,499 (8.5%), Benelux 2,482 (8.4%) and Switzerland 2,133 (7.2%). Within 12 months of signing up to the Madrid Protocol - one of two treaties that govern the system - the USA filed 1,734 (5.9%) applications to rank sixth among the biggest users of the Madrid system.

* Fast risers include China (+115%), Australia (+100.9%), Republic of Korea (+86.8%), Bulgaria (+82.5%), Japan (+75.6%), Slovenia (64.8%), Latvia (62.7%), Hungary (+47.4%), Austria (+36.8%), Turkey (+36.4%), United Kingdom (+36.1%), Italy (+30.5%), Norway (+29.8%), Slovakia (+27.7%), Singapore (+25.7%), Czech Republic (+24.7%), Sweden (+24.3%), Denmark (+17.9%) and Croatia (+15.4%).

* Top twenty users of the Madrid system in 2004 were Henkel (Germany), Hofer (Austria), Richter Gedeon (Austria), Janssen Pharmaceutica (Belgium), Beiersdorf AG (Germany), Siemens (Germany), Novartis (Switzerland), Philips Electronics (Netherlands), Aldi (Germany), Lidl Stifnung & Co (Germany), Deutsche Postbank AG (Germany), L’Oréal (France), Altana Pharma AG (Germany), Nestlé (Switzerland), Unilever (Netherlands), Volkswagen AG (Germany), Mip Metro Group Intellectual Property GmbH & Co. (Germany), Akzo Nobel Coatings International BV (Netherlands), Merck (France), and Biofarma (France).
The IPKat notes that these figures reflect the increasing globalisation of branding and marketing policies in our increasingly shrinking world.

Amended version of the WIPO press release here; original version here
Do you want to reuse the IPKat content? Please refer to our Policies section. If you have any queries or requests for permission, please get in touch with the IPKat team.
Print | Share by email

Comments

← Previous Post Next Post →